Form D · Other Health Care
Firefly BioWorks, Inc.
Cambridge, MA · CIK 0001502106
Offering snapshot reported Jul 21, 2014 · SEC filing
- Reported sold
- $775K Offering amount: $1.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 9, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 21, 2014 | Initial | $775,000 | No comparison | 6 | SEC filing |
| Oct 20, 2011 | Initial | $1,996,336 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-221475
Source: Form D, filed Jul 21, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Luigi Adamo | Director |
| Roger Dowd | Director |
| Patrick S. Doyle | Director |
| Andrea Gabrielle | Director |
| Davide M. Marini | Director, Executive |
| David Mc Clary | Director |
| John L. Miller | Director |
| Daniel C. Pregibon | Director, Executive |
| Rick Ryan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1 Kendall Square Building 1400 W
Cambridge, MA, 02139
Cambridge, MA, 02139